Birgit Grünberger

667 total citations
23 papers, 523 citations indexed

About

Birgit Grünberger is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Birgit Grünberger has authored 23 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in Birgit Grünberger's work include Colorectal Cancer Treatments and Studies (10 papers), Cancer Treatment and Pharmacology (7 papers) and Gastric Cancer Management and Outcomes (6 papers). Birgit Grünberger is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Cancer Treatment and Pharmacology (7 papers) and Gastric Cancer Management and Outcomes (6 papers). Birgit Grünberger collaborates with scholars based in Austria, Germany and Switzerland. Birgit Grünberger's co-authors include Michael Hejna, Florian Hucke, Matthias Pinter, Markus Peck‐Radosavljevic, A Maieron, Wolfgang Sieghart, Robert Königsberg, Rudolf Stauber, Manuela Schmidinger and Markus Raderer and has published in prestigious journals such as Journal of Clinical Oncology, Radiology and Annals of Oncology.

In The Last Decade

Birgit Grünberger

20 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Birgit Grünberger Austria	10	226	191	172	153	130	23	523
Xiaoli Chai China	7	311 1.4×	158 0.8×	113 0.7×	350 2.3×	92 0.7×	12	599
Yasunori Hasuike Japan	13	242 1.1×	30 0.2×	310 1.8×	162 1.1×	159 1.2×	61	552
Jun Chul Chung South Korea	13	64 0.3×	45 0.2×	231 1.3×	294 1.9×	98 0.8×	32	545
Giuseppe Cristofaro United States	6	175 0.8×	377 2.0×	71 0.4×	308 2.0×	205 1.6×	7	595
Robert Hüneburg Germany	13	124 0.5×	202 1.1×	205 1.2×	185 1.2×	108 0.8×	31	599
Daniela Proca United States	11	47 0.2×	50 0.3×	139 0.8×	168 1.1×	107 0.8×	21	325
Wallis Marsh United States	5	220 1.0×	63 0.3×	178 1.0×	167 1.1×	123 0.9×	7	429
Armelle Bardier–Dupas France	8	32 0.1×	114 0.6×	159 0.9×	199 1.3×	42 0.3×	11	446
F Gayral France	9	415 1.8×	68 0.4×	367 2.1×	390 2.5×	65 0.5×	34	668
Jiewen Peng China	8	171 0.8×	60 0.3×	48 0.3×	242 1.6×	168 1.3×	12	471

Countries citing papers authored by Birgit Grünberger

Since Specialization

Citations

This map shows the geographic impact of Birgit Grünberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Grünberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Grünberger more than expected).

Fields of papers citing papers by Birgit Grünberger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgit Grünberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Grünberger. The network helps show where Birgit Grünberger may publish in the future.

Co-authorship network of co-authors of Birgit Grünberger

This figure shows the co-authorship network connecting the top 25 collaborators of Birgit Grünberger. A scholar is included among the top collaborators of Birgit Grünberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgit Grünberger. Birgit Grünberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bartsch, Rupert, Zsuzsanna Bagó-Horváth, Daniel Egle, et al.. (2025). New Perspectives in the Management of Triple-Negative Breast Cancer. Breast Care. 1–14.

Gnant, Michael, Marija Balić, Gabriel Rinnerthaler, et al.. (2024). Evolving treatment paradigms after CDK4/6 inhibitors in advanced breast cancer. memo - Magazine of European Medical Oncology. 18(1). 4–18.

Fuereder, Thorsten, Konrad Klinghammer, Birgit Grünberger, et al.. (2024). 880P Paclitaxel plus cetuximab for the treatment of recurrent and/or metastatic head and neck cancer after first-line checkpoint inhibitor failure: Primary analysis from the pace ace trial. Annals of Oncology. 35. S629–S629. 2 indexed citations

Wöll, Ewald, Arno Amann, Wolfgang Eisterer, et al.. (2023). Treatment Algorithm for Patients With Gastric Adenocarcinoma: Austrian Consensus on Systemic Therapy – An Update. Anticancer Research. 43(7). 2889–2897. 2 indexed citations

Thaler, Josef, Sandro Anchisi, Christine Geffriaud-Ricouard, et al.. (2023). Quality of life, effectiveness, and safety of aflibercept plus FOLFIRI in older patients with metastatic colorectal cancer: An analysis of the prospective QoLiTrap study. Journal of Geriatric Oncology. 14(8). 101638–101638. 1 indexed citations

Rinnerthaler, Gabriel, Christian F. Singer, Edgar Petru, et al.. (2022). Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update. Wiener klinische Wochenschrift. 134(19-20). 683–692. 1 indexed citations

Hofheinz, Ralf‐Dieter, Sandro Anchisi, Birgit Grünberger, et al.. (2022). Real-World Evaluation of Quality of Life, Effectiveness, and Safety of Aflibercept Plus FOLFIRI in Patients with Metastatic Colorectal Cancer: The Prospective QoLiTrap Study. Cancers. 14(14). 3522–3522. 2 indexed citations

Moos, Roger von, J. Thaler, H. Kröning, et al.. (2021). PD-3 Impact of RAS status, prior targeted therapy, age, and gender on the activity of aflibercept plus FOLFIRI in patients with metastatic colorectal cancer: Real-world data from the QoLiTrap study. Annals of Oncology. 32. S199–S200.

Vormittag, Laurenz, Leopold Öhler, Birgit Grünberger, et al.. (2020). REGO-ACT: assessment of physical activity during treatment with regorafenib for metastatic colorectal cancer. Wiener klinische Wochenschrift. 132(15-16). 423–430. 3 indexed citations

10.

Kunit, Thomas, Birgit Grünberger, Wolfgang Loidl, et al.. (2017). Neoadjuvant Chemotherapy with Gemcitabine plus Cisplatin in Patients with Locally Advanced Bladder Cancer. Oncology. 93(1). 36–42. 19 indexed citations

11.

Grünberger, Birgit, et al.. (2015). Zusammenhang zwischen dem Betriebsstatus für das Virus des Porzinen Reproduktiven und Respiratorischen Syndroms und Organbefunden an Schlachtkörpern. Tierärztliche Praxis Ausgabe G Großtiere / Nutztiere. 43(3). 144–149. 1 indexed citations

12.

Grünberger, Birgit, et al.. (2014). Comparison of Different Commercial Serological Tests for the Detection ofToxoplasma gondiiAntibodies in Serum of Naturally Exposed Pigs. Zoonoses and Public Health. 62(2). 119–124. 30 indexed citations

13.

Pinter, Matthias, Florian Hucke, Ivo Graziadei, et al.. (2012). Advanced-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization versus Sorafenib. Radiology. 263(2). 590–599. 174 indexed citations

14.

Pinter, Matthias, Wolfgang Sieghart, Florian Hucke, et al.. (2011). Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib. Alimentary Pharmacology & Therapeutics. 34(8). 949–959. 63 indexed citations

15.

Pinter, Matthias, Wolfgang Sieghart, Florian Hucke, et al.. (2011). Prognostic factors in patients with hepatocellular carcinoma treated with Sorafenib. Zeitschrift für Gastroenterologie. 49(5). 1 indexed citations

16.

Eisterer, Wolfgang, Michael Fridrik, Birgit Grünberger, et al.. (2009). Oxaliplatin, irinotecan, and cetuximab in advanced gastric cancer. First efficacy results of a multicenter phase II trial (AGMT Gastric-2) of the Arbeitsgemeinschaft Medikamentoese Tumortherapie (AGMT). Journal of Clinical Oncology. 27(15_suppl). 4538–4538. 11 indexed citations

17.

Eisterer, Wolfgang, Michael Fridrik, Birgit Grünberger, et al.. (2008). Oxaliplatin, irinotecan and cetuximab in advanced gastric cancer: First results of a multicenter phase II trial (AGMT Gastric- 2. Journal of Clinical Oncology. 26(15_suppl). 15587–15587. 10 indexed citations

18.

Grünberger, Birgit, Markus Raderer, Manuela Schmidinger, & Michael Hejna. (2007). Palliative chemotherapy for recurrent and metastatic esophageal cancer.. PubMed. 27(4C). 2705–14. 63 indexed citations

19.

Grünberger, Birgit, W. Hauff, Julius Lukas, et al.. (2006). ‘Blind’ antibiotic treatment targeting Chlamydia is not effective in patients with MALT lymphoma of the ocular adnexa. Annals of Oncology. 17(3). 484–487. 49 indexed citations

20.

Grünberger, Birgit, Stefan Wöhrer, Berthold Streubel, et al.. (2006). Antibiotic Treatment Is Not Effective in Patients Infected With Helicobacter pylori Suffering From Extragastric MALT Lymphoma. Journal of Clinical Oncology. 24(9). 1370–1375. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact